Centene completed the divestiture of Magellan Specialty Health to Evolent Health.
Centene acquired Magellan, also known as NIA, in January 2022 as part of its acquisition of Magellan Health. Centene received approximately $660 million in proceeds at closing, subject to adjustment in accordance with the purchase agreement, with approximately $400 million paid in cash and the remainder paid in Evolent common stock. Read more.
